{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:03:16Z","timestamp":1780614196232,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1617,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770140"],"award-info":[{"award-number":["81770140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010218","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["182102410079"],"award-info":[{"award-number":["182102410079"]}],"id":[{"id":"10.13039\/501100010218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P41 GM103422"],"award-info":[{"award-number":["P41 GM103422"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R21 EY028705"],"award-info":[{"award-number":["R21 EY028705"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL121718"],"award-info":[{"award-number":["R01 HL121718"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1111\/jth.14127","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T15:11:23Z","timestamp":1523977883000},"page":"1164-1175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stabilization of warfarin\u2010binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition"],"prefix":"10.1016","volume":"16","author":[{"given":"G.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14127_bb0010","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1538-7836.2005.01419.x","article-title":"The vitamin K cycle","volume":"3","author":"Stafford","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14127_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0083-6729(07)00003-9","article-title":"The vitamin K cycle","volume":"78","author":"Oldenburg","year":"2008","journal-title":"Vitam Horm"},{"key":"10.1111\/jth.14127_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10409238.2013.791659","article-title":"Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase\u2010like1","volume":"48","author":"Van Horn","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1111\/jth.14127_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature02214","article-title":"Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2","volume":"427","author":"Rost","year":"2004","journal-title":"Nature"},{"key":"10.1111\/jth.14127_bb0030","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/jth.12306","article-title":"Evaluation of warfarin resistance using transcription activator\u2010like effector nucleases\u2010mediated vitamin K epoxide reductase knockout HEK293 cells","volume":"11","author":"Tie","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14127_bb0035","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1074\/jbc.M113.534446","article-title":"Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1\u2010Like 1 (VKORC1L1) are involved in its active site regeneration","volume":"289","author":"Tie","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0040","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1074\/jbc.M110.210971","article-title":"Human vitamin K 2,3\u2010epoxide reductase complex subunit 1\u2010like 1 (VKORC1L1) mediates vitamin K\u2010dependent intracellular antioxidant function","volume":"286","author":"Westhofen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0045","doi-asserted-by":"crossref","first-page":"28733","DOI":"10.1074\/jbc.M113.457119","article-title":"VKORC1L1, an enzyme rescuing the vitamin K 2,3\u2010epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy","volume":"288","author":"Hammed","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0050","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/j.1538-7836.2004.01002.x","article-title":"Vitamin K: lessons from the past","volume":"2","author":"Vermeer","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14127_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1538-7836.2010.04095.x","article-title":"Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment","volume":"9","author":"Watzka","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14127_bb0060","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","article-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","volume":"352","author":"Rieder","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14127_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2156-10-4","article-title":"Novel mutations in the VKORC1 gene of wild rats and mice\u2013a response to 50 years of selection pressure by warfarin?","volume":"10","author":"Rost","year":"2009","journal-title":"BMC Genet"},{"key":"10.1111\/jth.14127_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.abb.2011.08.010","article-title":"Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants","volume":"515","author":"Hodroge","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/jth.14127_bb0075","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1534\/genetics.104.040360","article-title":"The genetic basis of resistance to anticoagulants in rodents","volume":"170","author":"Pelz","year":"2005","journal-title":"Genetics"},{"key":"10.1111\/jth.14127_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nsmb.3333","article-title":"Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer","volume":"24","author":"Shen","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1111\/jth.14127_bb0085","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1074\/jbc.M500765200","article-title":"Membrane topology mapping of vitamin K epoxide reductase by in vitro translation\/cotranslocation","volume":"280","author":"Tie","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0090","doi-asserted-by":"crossref","first-page":"33945","DOI":"10.1074\/jbc.M112.402941","article-title":"Human vitamin k epoxide reductase and its bacterial homologue have different membrane topologies and reaction mechanisms","volume":"287","author":"Tie","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.05782-11","article-title":"Human herpesvirus 8 viral interleukin\u20106 interacts with splice variant 2 of vitamin K epoxide reductase complex subunit 1","volume":"86","author":"Chen","year":"2012","journal-title":"J Virol"},{"key":"10.1111\/jth.14127_bb0100","doi-asserted-by":"crossref","first-page":"15027","DOI":"10.1073\/pnas.1009972107","article-title":"Vitamin K epoxide reductase prefers ER membrane\u2010anchored thioredoxin\u2010like redox partners","volume":"107","author":"Schulman","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.14127_bb0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20151223","article-title":"The membrane topology of vitamin K epoxide reductase is conserved between human isoforms and the bacterial enzyme","volume":"473","author":"Cao","year":"2016","journal-title":"Biochem J"},{"key":"10.1111\/jth.14127_bb0110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/acs.biochem.7b00876","article-title":"Intramembrane thiol oxidoreductases: evolutionary convergence and structural controversy","volume":"57","author":"Li","year":"2018","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14127_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature08720","article-title":"Structure of a bacterial homologue of vitamin K epoxide reductase","volume":"463","author":"Li","year":"2010","journal-title":"Nature"},{"key":"10.1111\/jth.14127_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21767\/2471-8084.100024","article-title":"Identification of key functional residues in the active site of vitamin k epoxide reductase\u2010like protein (VKORC1L1)","volume":"2","author":"Matagrin","year":"2016","journal-title":"Biochem Mol Biol J"},{"key":"10.1111\/jth.14127_bb0125","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/ncomms4110","article-title":"Structures of an intramembrane vitamin K epoxide reductase homolog reveal control mechanisms for electron transfer","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/jth.14127_bb0130","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/blood-2013-05-501692","article-title":"Human VKORC1 mutations cause variable degrees of 4\u2010hydroxycoumarin resistance and affect putative warfarin binding interfaces","volume":"122","author":"Czogalla","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14127_bb0135","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1093\/nar\/gkm215","article-title":"Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes","volume":"35","author":"Wanrooij","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/jth.14127_bb0140","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2010-08-304303","article-title":"Functional study of the vitamin K cycle in mammalian cells","volume":"117","author":"Tie","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14127_bb0145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I\u2010TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1111\/jth.14127_bb0150","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein\u2010small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/jth.14127_bb0155","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jth.12185","article-title":"A new cell culture\u2010based assay quantifies vitamin K 2,3\u2010epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol\u2010driven VKOR assay","volume":"11","author":"Fregin","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14127_bb0160","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi00293a031","article-title":"Warfarin inhibition of vitamin K 2,3\u2010epoxide reductase in rat liver microsomes","volume":"22","author":"Fasco","year":"1983","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14127_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nsmb.3338","article-title":"Warfarin and vitamin K compete for binding to Phe55 in human VKOR","volume":"24","author":"Czogalla","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1111\/jth.14127_bb0170","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-2836(05)80134-2","article-title":"SCOP: a structural classification of proteins database for the investigation of sequences and structures","volume":"247","author":"Murzin","year":"1995","journal-title":"J Mol Biol"},{"key":"10.1111\/jth.14127_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acs.biochem.7b00874","article-title":"Membrane Protein Structure in Live Cells: Methodology for Studying Drug Interaction by Mass Spectrometry\u2010Based Footprinting","volume":"57","author":"Shen","year":"2018","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14127_bb0180","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1021\/ja00403a050","article-title":"Model studies for a molecular mechanism of action of oral anticoagulants","volume":"103","author":"Silverman","year":"1981","journal-title":"J Am Chem Soc"},{"key":"10.1111\/jth.14127_bb0185","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bmc.2007.01.014","article-title":"Synthesis and structure\u2010activity relationships of novel warfarin derivatives","volume":"15","author":"Gebauer","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1111\/jth.14127_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jmgm.2006.10.005","article-title":"A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR)","volume":"26","author":"Davis","year":"2007","journal-title":"J Mol Graph Model"},{"key":"10.1111\/jth.14127_bb0195","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1021\/ja00409a068","article-title":"Chemical model studies for the mechanism of vitamin K epoxide reductase","volume":"103","author":"Silverman","year":"1981","journal-title":"J Am Chem Soc"},{"key":"10.1111\/jth.14127_bb0200","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1016\/S0021-9258(18)32633-4","article-title":"Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin\u2010resistant rats","volume":"258","author":"Fasco","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14127_bb0205","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1182\/blood-2010-01-264598","article-title":"Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans","volume":"115","author":"Rennenberg","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14127_bb0210","doi-asserted-by":"crossref","first-page":"635e1","DOI":"10.1016\/j.amjmed.2015.11.032","article-title":"Warfarin and vascular calcification","volume":"129","author":"Poterucha","year":"2016","journal-title":"Am J Med"},{"key":"10.1111\/jth.14127_bb0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/ATVBAHA.114.304392","article-title":"Increased vascular calcification in patients receiving warfarin","volume":"35","author":"Tantisattamo","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14127_bb0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbacli.2015.08.002","article-title":"Long\u2010term warfarin therapy and biomarkers for osteoporosis and atherosclerosis","volume":"4","author":"Namba","year":"2015","journal-title":"BBA Clin"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14127","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622011138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622011138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:21:07Z","timestamp":1761535267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622011138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1538783622011138"],"URL":"https:\/\/doi.org\/10.1111\/jth.14127","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stabilization of warfarin\u2010binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}